Koninklijke Philips NV ADR (PHG) Gross Profit 2006–TTM

Name: Koninklijke Philips NV ADR (PHG) gross profit history 2006-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-19

Koninklijke Philips NV ADR annual gross profit for fiscal TTM was €8.1 billion, an increase of 0.7% from €8.1 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

PHG Annual Gross Profit

Gross Profit (annual)	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Gross Profit	€8.1B	€8.1B	€7.8B	€7.4B	€7.2B	€7.2B	€7.9B	€7.9B	€8.6B	€8.2B	€10.6B	€9.9B	€8.2B	€9.7B	€9.4B	€8.6B	€9.5B	€8.1B	€8.5B	€9.2B	€8.3B

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PHG Quarterly Gross Profit

Gross Profit (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Gross Profit	€2.1B	€1.8B	€2.3B	€1.9B	€2.0B	€1.8B	€2.0B	€2.0B	€2.0B

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Gross Profit at Comparable Companies

PEN Gross Profit — Penumbra Inc
SNN Gross Profit — Smith & Nephew SNATS Inc
BIO Gross Profit — Bio-Rad Laboratories Inc
GMED Gross Profit — Globus Medical
BIO.B Gross Profit — Bio-Rad Laboratories Inc
GKOS Gross Profit — Glaukos Corp

More PHG metrics: Revenue · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding

All PHG financial statements → Interactive PHG charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.